Case Studies
Oncology adherence program
Challenge
Clinical trials showed a 50% discontinuation of treatment within the first 8 weeks of therapy. This was due to several challenges: difficulty staying adherent to 2x daily oral oncolytic, older age of the patient population, and side effects.
Solution
Develop a patient community to seamlessly onboard patients to their oral oncolytic, provide educational content and insights to address their questions, and connect them with peers & community managers to leave ‘no patient alone’
- - AI matched patients for peer mentorship
- - Proactively educate on side effects
- - Push notifications for medication adherence & tracking
- - PSP connectivity cross-validated patient status
- - PSP ID used as gating mechanism

Results
- 86% of patients in app monthly
- 71% of patients stayed on therapy past 8-week checkpoint
- 73% of patients said the app helped them better manage and report side effects
- 70% of patients digested 4 educational health programs
We’re here to help you easily deliver best in class therapy management and patient support.